ArticleAmerican journal of clinical and experimental immunology2025
DPT has potential to be a prognostic biomarker and its correlation with immune infiltrates in prostate cancer.
Jieyu Jin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.